Blogopmaak
Press release on LUMC.nl
Annemieke Aartsma-Rus featured in a press release on the LUMC website last week.
In this she speaks about the role of Academic Pharma in supporting the process of delivering drugs that are not interesting for pharmaceutical companies, because of the low numbers of patients. Also, the role of DCRT in this process is raised.
To read the complete press release, go to Academic Pharma is key to support an effective drug development system for rare diseases
on the LUMC website.
published on Jul 7, 2021
Two new DCRT papers have been published online
Team DCRT went for its annual outing to Leiden's escape rooms
N=1 Collaborative is looking for communication trainees
PhD Position in treatment-response fluid biomarkers for ASO treatments
Short report of the 3rd Dutch Antisense Therapeutics Symposium in Rotterdam
DCRT travel grants awarded to 3 PhD students
Dr Marlen Lauffer, a senior researcher at the Dutch Center for RNA Therapeutics, was invited to give a talk at the Genomics England research summit in London on the 9th of July. She presented DCRT's work on the identification of genes and diseases and guidelines for patient selection.
Our paper on patient selection guidelines for ASO-based treatments has been published in Human Mutation!
A special cake for Bianca Zardetto to celebrate the acceptance of her article in Human Mutation
DCRT at the 3rd Dutch Antisense Therapeutics Symposium in Rotterdam